Nathalie Dubois-Stringfellow, SVP-CHIEF DEVELOPMENT OFFICER at SANGAMO THERAPEUTICS, INC (SGMO), sold 345,942 shares at $0.26 ($89K) on 2026-04-21, disclosed to the SEC on 2026-04-23.
Open-market sale of $89k SGMO by SVP-CHIEF DEVELOPMENT OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.